FANTAPPIE', ORNELLA
 Distribuzione geografica
Continente #
NA - Nord America 280
EU - Europa 37
AS - Asia 33
AF - Africa 4
SA - Sud America 2
Totale 356
Nazione #
US - Stati Uniti d'America 276
CN - Cina 17
PL - Polonia 8
IE - Irlanda 7
IN - India 7
IT - Italia 6
VN - Vietnam 6
FR - Francia 5
CA - Canada 4
ZA - Sudafrica 4
DE - Germania 3
GB - Regno Unito 3
CL - Cile 2
RU - Federazione Russa 2
SG - Singapore 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
FI - Finlandia 1
NL - Olanda 1
Totale 356
Città #
Fairfield 42
Houston 25
Buffalo 23
Santa Cruz 22
Ashburn 20
Seattle 20
Ann Arbor 13
Wilmington 12
Woodbridge 12
Cambridge 9
Warsaw 8
Bengaluru 7
Dublin 7
Beijing 6
Dong Ket 6
Florence 5
Chicago 4
Clearwater 4
Mountain View 4
Guangzhou 3
Las Vegas 3
Muizenberg 3
Phoenix 3
Riva 3
Boardman 2
Lake Forest 2
Los Angeles 2
Paris 2
San Diego 2
Singapore 2
Bremen 1
Dallas 1
Easton 1
Hangzhou 1
Helsinki 1
Henderson 1
Huntsville 1
Jersey City 1
Milpitas 1
Moscow 1
Niagara Falls 1
Ottawa 1
Pittsburgh 1
Rolling Meadows 1
Saint Louis 1
San Jose 1
Scottsdale 1
Scranton 1
Shanghai 1
Silverton 1
Toronto 1
University Park 1
Washington 1
Wuhan 1
Totale 300
Nome #
Lipid peroxidation and cyclooxygenase-2 activity in human hepatocellular carcinoma cell lines with and without multiple drug resistance: correlation with cell growth, file e398c37c-d71b-179a-e053-3705fe0a4cff 134
Mitochondria of a human multidrug-resistant hepatocellular carcinoma cell line constitutively express inducible nitric oxide synthase in the inner membrane, file e398c37b-8209-179a-e053-3705fe0a4cff 125
Aldoxorubicin and Temozolomide combination in a xenograft mice model of human glioblastoma., file e398c37e-1a80-179a-e053-3705fe0a4cff 117
Totale 376
Categoria #
all - tutte 612
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 612


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201929 0 0 0 0 0 0 0 0 0 7 10 12
2019/2020102 8 12 1 6 14 12 11 10 12 5 6 5
2020/202164 4 6 2 5 11 4 2 3 7 4 8 8
2021/202286 12 2 6 12 12 1 1 4 4 0 22 10
2022/202355 0 8 21 11 1 7 4 0 0 1 2 0
2023/202419 0 2 2 2 2 0 7 2 2 0 0 0
Totale 376